A statement from Baroness Sally Morgan, CUH Chair and Roland Sinker, CEO: "We are delighted the Chancellor announced that delivering Cambridge Cancer Research Hospital remains a top priority for the UK Government’s plans to unlock the potential of the Oxford-Cambridge growth corridor, and to kick-start the UK’s economy.
Architect image of Cambridge Cancer Research Hospital and neighbours AstraZeneca (bottom left), Royal Papworth Hospital (bottom right) and Addenbrooke's Hospital.
Cambridge Cancer Research Hospital will change the way we detect and treat cancer.
It will also be a driver for growth and international competitiveness by bringing together clinical expertise from Cambridge University Hospitals NHS Foundation Trust (CUH) with world-class scientists from the University of Cambridge, Cancer Research UK Cambridge Centre, and partners from industry.
Anything invented here will go directly into NHS care, to be rolled-out across the UK, catalysing the translation of life sciences and technology into new technologies and techniques."